Add your Event List View →

Events Calendar (October 2023)

March 1 April 1 May 2 June July 1 August September October November December January February
 
October
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
26
27
28
29
30
1
2
Formulation & Delivery US 2023

Formulation & Delivery US 2023

Join leaders, experts and researchers at West Coast’s scientific Hub – San Diego, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations in formulation, drug delivery & inhaled science.

Formulation & Delivery US 2023 features 2 outstanding programmes, bringing together key opinion leaders under one roof. The events provide a unique networking platform which consists of vital discussion topics in: Formulation & Drug Delivery and Inhalation & Respiratory Drug Delivery.

5th Annual
Formulation & Drug Delivery
US Congress

Hear form leading experts in biologics & small molecule formulation development, drug delivery, utilisation of nanotechnology and advances in lyophilisation techniques.

5th Annual
Inhalation & Respiratory Drug Delivery US Congress

Exceptional speakers will discuss the latest challenges and innovations in inhaled therapies formulation, delivery and moving towards sustainable device development.

3
Formulation & Delivery US 2023

Formulation & Delivery US 2023

Join leaders, experts and researchers at West Coast’s scientific Hub – San Diego, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations in formulation, drug delivery & inhaled science.

Formulation & Delivery US 2023 features 2 outstanding programmes, bringing together key opinion leaders under one roof. The events provide a unique networking platform which consists of vital discussion topics in: Formulation & Drug Delivery and Inhalation & Respiratory Drug Delivery.

5th Annual
Formulation & Drug Delivery
US Congress

Hear form leading experts in biologics & small molecule formulation development, drug delivery, utilisation of nanotechnology and advances in lyophilisation techniques.

5th Annual
Inhalation & Respiratory Drug Delivery US Congress

Exceptional speakers will discuss the latest challenges and innovations in inhaled therapies formulation, delivery and moving towards sustainable device development.

4
5
6
7
8
9
10
11
12
Biomarkers US 2023

Biomarkers US 2023

Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine

Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations working in the biomarker industry across multiple therapeutic areas, allowing attendees to gain insights into the latest novel biomarker data and technologies.

Agenda at a Glance

Day One

Biomarkers in Drug Discovery & Translational Sciences

  • Qualification of biomarkers for translational studies
  • Efficacy and PK/PD biomarkers in drug development
  • Case studies in biomarker discovery and validation

Biomarkers for Diagnostic Development

  • Diagnostic development: Companion, Tissue & PoC
  • Case studies in early detection and personalised medicine

Biomarkers for Clinical Development

  • Implementing clinical biomarkers across: oncology, cardiometabolic and infectious
    disorders
  • Transforming clinical development through biomarker driven clinical trial design

 

Day Two

New Biomarker Technologies & Data

  • Imaging technologies, CNS imaging techniques and digital pathology
  • Multiplexing technologies, flow cytometry and mass spectrometry
  • Immunoassays and screening processes
    Genomic Markers in Precision Medicine &

Genomic Markers in Precision Medicine & Clinical Practice

  • Translating genomic markers into the clinic
  • The role of liquid biopsy in precision medicine
Immuno US 2023

Immuno US 2023

Discuss the latest strategies to harness the immune system for the development of innovative therapeutics.

Featuring 30+ presentations, the event brings together over 120 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.

Agenda at a Glance

Day One

Track 1: Discovery & Development: Cell Therapies & Antibody Approaches

  • NextGen cell-based immunotherapies: CAR-T, TCR, and TIL  
  • Case studies in bispecific antibodies and checkpoint inhibitors 
  • Workshop: Improving The Therapeutic Index For Cell Engagers 

Track 2: Biomarkers, Precision Medicine & Spatial Biology in Immuno-Oncology

  • Biomarker strategies in the era of PD-1 checkpoint combination therapies​ 
  • New technologies: CyTOF, mass spec, multiplexing, immunohistochemistry, serum biomarkers 
  • Spatial biology to improve clinical trial outcomes and biomarker discovery 
  • Workshop: Harnessing Spatial Technologies For Immunotherapy Research 

Day Two

Track 1: Discovery & Development: Intratumoral Immuno- & Combination Therapies​ & Small Molecules as IO Therapeutics

Part 1 – Intra-tumoral & Combination Therapies  

  • Oncolytic and non-oncology viruses and agonists 
  • Cancer vaccine development 
  • Rationale of different combinations, including combination of IO agents as well as radiotherapy & chemotherapy​ 

Part 2 – Small Molecules as Immuno-Oncology Therapeutics 

  • Advances in modulating immuno-metabolism and immuno-suppression with small molecules 
  • New approaches for small molecule IO targets  
  • Workshop: Small Molecules As IO Targets  

Track 2: Translational & Preclinical and Clinical Development

  • Preclinical models, including humanised & 3D mouse models 
  • Translational imaging and screening methods 
  • Safety & Toxicity considerations 
  • Approaches to clinical trial design & development 

 

13
Biomarkers US 2023

Biomarkers US 2023

Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine

Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations working in the biomarker industry across multiple therapeutic areas, allowing attendees to gain insights into the latest novel biomarker data and technologies.

Agenda at a Glance

Day One

Biomarkers in Drug Discovery & Translational Sciences

  • Qualification of biomarkers for translational studies
  • Efficacy and PK/PD biomarkers in drug development
  • Case studies in biomarker discovery and validation

Biomarkers for Diagnostic Development

  • Diagnostic development: Companion, Tissue & PoC
  • Case studies in early detection and personalised medicine

Biomarkers for Clinical Development

  • Implementing clinical biomarkers across: oncology, cardiometabolic and infectious
    disorders
  • Transforming clinical development through biomarker driven clinical trial design

 

Day Two

New Biomarker Technologies & Data

  • Imaging technologies, CNS imaging techniques and digital pathology
  • Multiplexing technologies, flow cytometry and mass spectrometry
  • Immunoassays and screening processes
    Genomic Markers in Precision Medicine &

Genomic Markers in Precision Medicine & Clinical Practice

  • Translating genomic markers into the clinic
  • The role of liquid biopsy in precision medicine
Immuno US 2023

Immuno US 2023

Discuss the latest strategies to harness the immune system for the development of innovative therapeutics.

Featuring 30+ presentations, the event brings together over 120 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.

Agenda at a Glance

Day One

Track 1: Discovery & Development: Cell Therapies & Antibody Approaches

  • NextGen cell-based immunotherapies: CAR-T, TCR, and TIL  
  • Case studies in bispecific antibodies and checkpoint inhibitors 
  • Workshop: Improving The Therapeutic Index For Cell Engagers 

Track 2: Biomarkers, Precision Medicine & Spatial Biology in Immuno-Oncology

  • Biomarker strategies in the era of PD-1 checkpoint combination therapies​ 
  • New technologies: CyTOF, mass spec, multiplexing, immunohistochemistry, serum biomarkers 
  • Spatial biology to improve clinical trial outcomes and biomarker discovery 
  • Workshop: Harnessing Spatial Technologies For Immunotherapy Research 

Day Two

Track 1: Discovery & Development: Intratumoral Immuno- & Combination Therapies​ & Small Molecules as IO Therapeutics

Part 1 – Intra-tumoral & Combination Therapies  

  • Oncolytic and non-oncology viruses and agonists 
  • Cancer vaccine development 
  • Rationale of different combinations, including combination of IO agents as well as radiotherapy & chemotherapy​ 

Part 2 – Small Molecules as Immuno-Oncology Therapeutics 

  • Advances in modulating immuno-metabolism and immuno-suppression with small molecules 
  • New approaches for small molecule IO targets  
  • Workshop: Small Molecules As IO Targets  

Track 2: Translational & Preclinical and Clinical Development

  • Preclinical models, including humanised & 3D mouse models 
  • Translational imaging and screening methods 
  • Safety & Toxicity considerations 
  • Approaches to clinical trial design & development 

 

14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
6
<< September November >>

← Back to List of Events